8-K: RYTHM Reports Q4, Full Year 2025 Results Amid Strategic Shift

RYTHM, Inc. announced significant revenue growth and strategic expansion in the hemp-derived THC market for Q4 and full year 2025, despite reporting substantial operating losses.

Summary

• For the fourth quarter ended December 31, 2025, revenue from continuing operations increased 164% to $10.7 million, up from $4.0 million in the prior quarter.
• Gross profit from continuing operations for Q4 2025 was $8.0 million, representing 75% of revenue, a significant increase from $1.4 million or 34% of revenue in the prior quarter.
• The company reported an operating loss from continuing operations of $12.9 million for Q4 2025, primarily due to an $8.5 million non-cash impairment charge.
• RYTHM, Inc. ended the year with a cash balance of $32.2 million.
• For the full year ended December 31, 2025, revenue was $17.28 million, a substantial increase from $18 thousand in 2024.
• Full year 2025 gross profit was $10.19 million, compared to a gross loss of $71 thousand in 2024.
• The net loss for the full year 2025 was $33.26 million, an improvement from a net loss of $41.75 million in 2024.
• Key strategic achievements in 2025 included the acquisition of a portfolio of brand intellectual property (RYTHM, Dogwalkers, incredibles, Beboe, others), generating $7.8 million in licensing fees from Green Thumb Industries, establishing a beverage retail footprint of over 6,000 locations across 18 states, and securing placement of Seorita THC Margaritas in over 800 Circle K stores.
• RYTHM also launched Seorita THC Margaritas and RYTHM Beverages at Chicago's United Center through a multi-year partnership, marking the first THC beverages available at a major U.S. arena.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as moderately positive, reflecting strong strategic execution and significant revenue growth in a challenging market, balanced by substantial operating losses and cash burn associated with aggressive expansion and an impairment charge. The long-term potential is high, but current financial performance indicates a company in an investment phase.

Positives

• Fourth quarter 2025 revenue from continuing operations surged 164% to $10.7 million, demonstrating strong sequential growth.
• Gross profit margin from continuing operations significantly improved to 75% in Q4 2025, up from 34% in the prior quarter, driven by $7.0 million in licensing revenue.
• Full year 2025 revenue of $17.28 million represents a dramatic increase from $18 thousand in 2024, reflecting successful strategic shifts and brand acquisitions.
• The company successfully acquired a portfolio of iconic brand intellectual property, including RYTHM, Dogwalkers, and incredibles.
• Generated $7.8 million in licensing fees in 2025 by licensing brands to cannabis operator Green Thumb Industries.
• Expanded beverage retail footprint to over 6,000 locations across 18 states, significantly increasing market penetration.
• Secured a major distribution deal for Seorita THC Margaritas in over 800 Circle K stores, marking the largest U.S. convenience store rollout of hemp-derived THC beverages to date.
• Achieved a historic partnership with Chicago's United Center, making Seorita THC Margaritas and RYTHM Beverages the first THC beverages available at a major U.S. arena.

Negatives

• Reported an operating loss from continuing operations of $12.9 million in Q4 2025, primarily due to an $8.5 million non-cash impairment charge.
• Full year 2025 operating loss from continuing operations worsened to $32.34 million, compared to $5.07 million in 2024.
• The company incurred a net loss of $33.26 million for the full year 2025, despite an improvement from the prior year.
• Cash used in operating activities increased significantly to $23.54 million in 2025 from $11.58 million in 2024, indicating increased cash burn.
• Cash used in investing activities dramatically increased to $55.08 million in 2025 from $54 thousand in 2024, reflecting substantial investments.

Risks

• The company faces persistent structural and regulatory headwinds in the THC category.
• There is a risk that Congress does not amend or repeal the pending federal prohibition on hemp-derived THC products prior to its November 2026 effective date.
• Forward-looking statements involve known and unknown risks, uncertainties, and other important factors that may cause actual results to differ materially.

Future Outlook

RYTHM, Inc. anticipates continued momentum for hemp-derived beverages and potential trends in the hemp-derived beverage and alcohol markets. The company's forward-looking statements include expectations regarding future financial results, regulatory trends, and potential annual licensing revenue, contingent on the evolving regulatory landscape for THC products.

Management Comments

• Chairman and Interim CEO Ben Kovler stated that 2025 was a 'transformational year' for RYTHM, Inc., marked by a new name, ticker, and strategic direction as the company expanded its role in the THC category.
• Kovler highlighted that Q4 licensing revenue of $7.0 million was a key contributor to the company's total gross margins of approximately 75% for the quarter.
• Management noted that despite persistent structural and regulatory headwinds, consumer demand for THC continues to rise.
• Kovler emphasized the company's commitment to providing consumers with access to safe, high-quality THC products where they already live, shop, and gather.
• The partnership with Chicago's United Center was described as a 'historic first' and a 'powerful example of real progress' with a world-class partner recognizing evolving consumer demand.
• Management believes that owning leading U.S. brands provides long-term strategic value as the hemp and cannabis market continues to evolve globally.

Industry Context

StockSavvy.ai notes that RYTHM, Inc.'s strategic pivot towards hemp-derived THC products and brand licensing positions it within a rapidly evolving, yet highly regulated, segment of the consumer goods market. The company's expansion into mainstream retail and entertainment venues like Circle K and United Center reflects a broader industry trend of increasing consumer acceptance and demand for THC products, even as federal policy lags. The emphasis on 'Americans just say no to alcohol' suggests a strategic play to capture market share from the traditional alcohol industry, aligning with a growing wellness trend. However, the significant regulatory risk, particularly the pending federal prohibition on hemp-derived THC products, underscores the volatile nature of this nascent industry.

Comparison to Industry Standards

• The filing does not provide specific comparisons to other companies, projects, or global benchmarks within the hemp-derived THC or cannabis industry.

Related Party Transactions

• The company has significant related party debt, with $27.0 million classified as current and $45.0 million as non-current.

Stakeholder Impact

• Shareholders: Potential for long-term value creation through strategic growth and market expansion, but currently facing significant losses and potential dilution from warrants and convertible notes.
• Customers: Increased access to a wider range of hemp-derived THC products through expanded retail footprints and new partnerships.
• Employees: Continued focus on growth and expansion may lead to job opportunities and stability within the company.
• Green Thumb Industries: Benefits from licensing agreements, generating revenue for RYTHM and expanding product offerings for Green Thumb.

Next Steps

• Continue to expand the retail footprint for hemp-derived THC beverages.
• Further integrate and leverage acquired brand intellectual property.
• Navigate the evolving regulatory landscape for THC products, particularly concerning the pending federal prohibition.

Key Dates

Recommendation

While RYTHM, Inc. demonstrates impressive revenue growth and strategic execution in a high-potential market, the significant operating losses, increased cash burn, and substantial regulatory risks warrant a 'hold' recommendation. Existing investors should monitor the company's ability to convert strategic gains into profitability and navigate the complex regulatory environment, particularly the November 2026 federal prohibition deadline. New investors might find the risk-reward profile too speculative without clearer paths to sustained profitability and regulatory certainty.

Keywords

Hemp-derived THC, Cannabis, Beverages, Licensing, Consumer Goods, RYTHM Inc., Financial Results, Brand Acquisition, Retail Expansion